Jennaro, Theodore S.
Fang, Fang
Kidwell, Kelley M.
Smith, Ellen M. Lavoie
Vangipuram, Kiran
Burness, Monika L.
Griggs, Jennifer J.
Van Poznak, Catherine
Hayes, Daniel F.
Henry, N. Lynn
Hertz, Daniel L. https://orcid.org/0000-0003-0501-1035
Funding for this research was provided by:
National Cancer Institute (P30CA046592)
National Center for Advancing Translational Sciences (KL2TR000434, 2UL1TR000433)
Article History
Received: 29 October 2019
Accepted: 29 February 2020
First Online: 12 March 2020
Compliance with ethical standards
:
: Theodore Jennaro declares that he has no conflict of interest. Fang Fang declares that she has no conflict of interest. Kelley M Kidwell declares that she has no conflict of interest. Ellen M Lavoie Smith declares that she has no conflict of interest. Kiran Vangipuram declares that he has no conflict of interest. Monika Burness declares that she has no conflict of interest. Jennifer Griggs declares that she has no conflict of interest. Catherine Van Poznak has received research funding from Bayer for an unrelated project. Daniel Hayes declares that he has no conflict of interest. N. Lynn Henry is a local PI of a pharma-sponsored trial for Pfizer, Abbvie, and Innocrin Pharmaceuticals that are unrelated to this work. Daniel Hertz received research grants from The Michigan Institute for Clinical Health & Research (MICHR) to conduct this study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.